In diabetics with hypertension, which of the following statements is true about renal-protective therapy?

• A. ACE inhibitors reduce microalbuminuria and protect renal function
• B. Beta blockers are preferred for kidney protection
• C. Calcium channel blockers have equal renal protection
• D. Thiazide diuretics provide superior renal protection

Answer: (A)

In diabetics with hypertension, protecting the kidneys relies on lowering pressure inside the glomerulus and reducing protein leakage into the urine. ACE inhibitors do this by blocking angiotensin II, which normally constricts the efferent arteriole. With the efferent arteriole dilated, glomerular capillary pressure falls, proteinuria (microalbuminuria) decreases, and the progression of diabetic nephropathy is slowed. This renal protection goes beyond just lowering blood pressure, making ACE inhibitors the strongest option for preserving renal function in this setting.

Beta blockers mainly manage heart rate and BP but don’t specifically reduce intraglomerular pressure or microalbuminuria. Calcium channel blockers and thiazide diuretics improve BP control but don’t offer the same level of renal protection against diabetic nephropathy.